Anokion Competitors and Similar CompaniesClear all
Immunocore's competitors and similar companies include Monte Rosa Therapeutics.
 Immunocore Immunocore is a T cell receptor (TCR) biotechnology company working to create biological therapies for oncology and infectious and autoimmune diseases. |  Monte Rosa Therapeutics Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways. | |
Founding Date | Founding Date 2008 | Founding Date 2018 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Milton, GB HQ Conshohocken, US Rockville, US | Locations Boston, US HQ Basel, CH Basel, CH Basel, CH Boston, US Cambridge, US |
Employees | Employees 493 | Employees 75 |
Valuation ($) | Valuation ($) 1.6 b | Valuation ($) 575.1 m |
Financial | ||
Revenue (est.) | Revenue (est.) $400m (FY, 2025) | Revenue (est.) $123.7m (FY, 2025) |
Net income | Net income ($35.5m) (FY, 2025) | Net income ($38.6m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 565m | Total funding raised $ 223.5m |
For sources of this data, please see the company profile
View Company Profiles
Monte Rosa Therapeutics
HQ
Boston, US
Employees
75
Monte Rosa Therapeutics is a biopharmaceutical company that develops cancer therapeutics intended to modulate protein degradation pathways.
View company